Newcastle Disease Virus Antikörper
Kurzübersicht für Newcastle Disease Virus Antikörper (ABIN2475864)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Glycoprotein haemagglutinin-neuraminidase of Newcastle Disease Virus (La-Sota strain)
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus." in: Current cancer drug targets, Vol. 7, Issue 2, pp. 157-67, (2007) (PubMed).
-
: "Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus." in: Current cancer drug targets, Vol. 7, Issue 2, pp. 157-67, (2007) (PubMed).
-
- Newcastle Disease Virus (NDV)
-
Andere Bezeichnung
- NEWCASTLE DISEASE VIRUS
-
Substanzklasse
- Virus
-
Hintergrund
- Synonyms: NDV
Target
-